Romiplostim
In the US, Romiplostim (romiplostim systemic) is a member of the drug class platelet-stimulating agents and is used to treat Idiopathic Thrombocytopenic Purpura.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
B02BX04
CAS registry number (Chemical Abstracts Service)
0267639-76-9
Chemical Formula
C2634-H4086-N722-O790-S18
Molecular Weight
59085
Therapeutic Categories
Hematopoietic growth factor: Stimulation of thrombopoiesis
Hemostatic agent: Treatment of thrombocytopenia
Thrombopoietin receptor agonist
Chemical Names
L-methionyl [human immunglobulin heavy constant gamma 1-(227 C-terminal residues)-peptide (Fc fragment)] fusion protein with 41 amino acids peptide, (7-7':10,10')-bisdisulfide dimer (WHO)
Methionyl, 227 amino acid C-terminal Immunoglobulin G1 (human Fc fragment) fusion protein with 41 amino acid peptide, dimer (USAN)
Foreign Names
- Romiplostimum (Latin)
- Romiplostim (German)
- Romiplostim (French)
- Romiplostim (Spanish)
Generic Names
- Romiplostim (OS: USAN, BAN)
- AMG 531 (IS: Amgen)
Brand Names
- Nplate
Amgen, Austria; Amgen, Australia; Amgen, Belgium; Amgen, Canada; Amgen, Czech Republic; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Greece; Amgen, Iceland; Amgen, Latvia; Amgen, Netherlands; Amgen, Norway; Amgen, Romania; Amgen, Sweden; Amgen, Slovenia; Amgen, Slovakia; Amgen, United States; Amgen Dompè, Italy; Amgen Europe, Denmark; Amgen Europe, Lithuania; Amgen Ltd., Ireland; Amgen Switzerland, Switzerland
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
